Who owns Medline Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of MDLN from SEC Form 13F filings across 405 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 405 institutions disclosed 751.2M shares of Medline Inc. worth $29.65B — about 87.7% of shares outstanding; the largest disclosed holder is Carlyle Group Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
405
13F holders
$29.65B
value, 2026 filers
87.7%
of shares outstanding (751.2M sh)
173
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of MDLN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Carlyle Group Inc. | 187.1M | $7.38B | 73.8% | 21.8% | 0.0% |
| 2 | H&F Corporate Investors X, Ltd. | 70.9M | $2.80B | 100.0% | 8.3% | -18.0% |
| 3 | FMR LLC | 47.0M | $1.85B | 0.1% | 5.5% | +28.5% |
| 4 | Capital Research Global Investors | 40.0M | $1.58B | 0.2% | 4.7% | +72.5% |
| 5 | Invesco Ltd. | 38.3M | $1.51B | 0.1% | 4.5% | +82.9% |
| 6 | BlackRock, Inc. | 26.4M | $1.04B | 0.0% | 3.1% | +56.0% |
| 7 | MORGAN STANLEY | 21.6M | $852.1M | 0.0% | 2.5% | +37.6% |
| 8 | LONE PINE CAPITAL LLC | 21.0M | $827.0M | 5.1% | 2.4% | +77.9% |
| 9 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 19.9M | $787.1M | 0.2% | 2.3% | +71.9% |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 17.8M | $702.7M | 0.0% | 2.1% | +21.0% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 16.8M | $661.8M | 0.0% | 2% | +18.6% |
| 12 | Egerton Capital (UK) LLP | 16.5M | $649.6M | 6.3% | 1.9% | +277.3% |
| 13 | Jupiter Topco LLCNEW | 15.9M | $625.4M | 0.3% | 1.9% | new |
| 14 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 12.0M | $471.6M | 0.4% | 1.4% | +172.7% |
| 15 | BAILLIE GIFFORD & CO | 11.3M | $447.4M | 0.4% | 1.3% | +13.7% |
| 16 | NORGES BANKNEW | 8.5M | $334.3M | 0.0% | 1% | new |
| 17 | STATE STREET CORP | 8.4M | $333.2M | 0.0% | 1% | +75.2% |
| 18 | GEODE CAPITAL MANAGEMENT, LLC | 7.9M | $312.7M | 0.0% | 0.9% | +27.0% |
| 19 | SurgoCap Partners LP | 7.5M | $295.3M | 9.5% | 0.9% | +23.2% |
| 20 | WCM INVESTMENT MANAGEMENT, LLC | 7.4M | $293.0M | 0.5% | 0.9% | +2.5% |
| 21 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 7.4M | $290.1M | 0.4% | 0.9% | +47.1% |
| 22 | BANQUE PICTET & CIE SA | 7.3M | $288.4M | 1.8% | 0.9% | +414.6% |
| 23 | Alyeska Investment Group, L.P. | 6.8M | $268.6M | 0.7% | 0.8% | +131.8% |
| 24 | UBS Group AG | 6.4M | $253.6M | 0.0% | 0.8% | +101.5% |
| 25 | BESSEMER GROUP INC | 5.6M | $222.8M | 0.3% | 0.7% | +61.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.